These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 2538263

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Usefulness of segmental Lp-TAE using lipiodol mixed with anticancer agent for inoperable hepatocellular carcinoma].
    Matsuo N, Nishimine K, Uchida H, Nagano N, Nishimura Y, Oiyong G, Sakaguchi H, Yoshioka T, Ohue S, Ohishi H.
    Nihon Shokakibyo Gakkai Zasshi; 1992 Jul; 89(7):1415-24. PubMed ID: 1325006
    [Abstract] [Full Text] [Related]

  • 5. [The clinical course of nodular type hepatocellular carcinomas after transcatheter arterial embolization (TAE) therapy].
    Suyama Y, Kitagawa Y, Horishi M, Shizumi Y, Yashige H, Fujii H, Miyoshi M.
    Gan No Rinsho; 1989 Aug; 35(9):983-9. PubMed ID: 2475651
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma.
    Hirai K, Kawazoe Y, Yamashita K, Aoki Y, Fujimoto T, Sakai T, Majima Y, Abe M, Tanikawa K.
    Cancer Chemother Pharmacol; 1989 Aug; 23 Suppl():S37-41. PubMed ID: 2538264
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Behavior of anti-cancer drug of transcatheter hepatic segmental arterial chemoembolization using lipiodol mixed with an anti-cancer drug followed by gelatin sponge assessed by Tc-99m pertechnetate].
    Sakaguchi H, Yoshimura H, Nishimura Y, Iwata K, Ohishi H, Uchida H.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1725-30. PubMed ID: 2167644
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Preoperative chemo-embolization for treatment of hepatocellular carcinoma].
    Okamura J, Monden M, Sakon M, Mori T, Kuroda C, Yoshioka H, Sakurai M, Wakasa K.
    Gan To Kagaku Ryoho; 1985 May; 12(5):1019-24. PubMed ID: 2986558
    [Abstract] [Full Text] [Related]

  • 16. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
    Hirashima N.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
    [Abstract] [Full Text] [Related]

  • 17. Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis.
    Nakao N, Uchida H, Kamino K, Nishimura Y, Ohishi H, Takayasu Y, Miura K.
    Cardiovasc Intervent Radiol; 1994 Feb; 17(2):76-80. PubMed ID: 8013027
    [Abstract] [Full Text] [Related]

  • 18. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
    Hirashima N, Sakakibara K, Itazu I, Hirai T, Nemoto A, Matsuura H, Kumada K, Nojiri O, Kano H.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of the effect of transcatheter arterial embolization as preoperative therapy of hepatocellular carcinoma].
    Minematsu S, Taki Y, Tani T, Ozawa K, Tobe T.
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1120-8. PubMed ID: 2997499
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.